Last Price
74.10
Today's Change
+0.62 (0.84%)
Day's Change
72.93 - 74.15
Trading Volume
956,776
Market Cap
17 Billion
Shares Outstanding
233 Million
Avg Volume
1,412,672
Avg Price (50 Days)
74.32
Avg Price (200 Days)
72.86
PE Ratio
38.20
EPS
1.94
Earnings Announcement
29-Jul-2024
Previous Close
73.48
Open
73.47
Day's Range
72.9316 - 74.15
Year Range
64.02 - 82.45
Trading Volume
956,776
1 Day Change
0.84%
5 Day Change
-0.07%
1 Month Change
-0.55%
3 Month Change
-4.98%
6 Month Change
1.58%
Ytd Change
2.26%
1 Year Change
-4.40%
3 Year Change
6.40%
5 Year Change
56.53%
10 Year Change
190.99%
Max Change
2999.61%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Instruments & Supplies
Description:
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.